Cleveland Clinic has appointed an interim chief investment officer amid the planned departure of the system’s longtime leader.
Timothy Compan was named to the interim role, effective immediately, a health system spokesperson said in a statement shared with Becker’s on March 24. He brings more than eight years of experience in the system’s investment office, most recently serving as manager director for the Cleveland Clinic Investment Office credit portfolio.
Stefan Strein became the system’s inaugural chief investment officer in 2015 and will depart the organization April 10. He was appointed president, CEO and chief investment officer of Chapel Hill, N.C.-based UNC Management Co., which provides investment management services to the Chapel Hill-based University of North Carolina System and its affiliated endowments and foundations.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
